Mandatory Recall of GH Kush Pops

State Orders Recall of GH Kush Pops After THC Levels Exceed Legal Limit

New Mexico regulators have issued a mandatory recall of a medical cannabis edible after testing revealed THC levels far above what state law allows.

According to reporting by Grant County Beat, the recall involves “GH Kush Pops,” a cannabis-infused lollipop product manufactured for the medical market. The action was ordered by the New Mexico Cannabis Control Division after the product was found to contain significantly more THC per serving than permitted under New Mexico regulations.

State rules cap medical cannabis edibles at 50 milligrams of THC per serving. However, GH Kush Pops were found to contain 200 milligrams of THC per package, divided into two 100-milligram lollipops. That amount is double the legal limit per individual serving and four times the allowable amount if considered as a single serving product.

Regulators classified the issue as a labeling and dosage compliance violation serious enough to warrant a mandatory recall. Licensed retailers that carried the product were instructed to immediately remove it from shelves and halt further sales. Patients who purchased the affected lollipops are being advised to stop using the product and contact the retailer for return or disposal instructions.

While cannabis affects individuals differently, consuming higher-than-expected THC doses can increase the likelihood of unwanted side effects. These may include anxiety, dizziness, rapid heart rate, impaired coordination, or extreme sedation—particularly for medical patients who rely on predictable dosing for symptom management.

The recall highlights the importance of accurate potency testing and clear labeling in the state’s regulated cannabis market. For medical patients, dosage consistency is not just a regulatory requirement but a health and safety issue. Many rely on specific THC levels to manage chronic pain, nausea, PTSD, or other qualifying conditions.

The Cannabis Control Division maintains that enforcement actions such as recalls are part of maintaining consumer confidence and ensuring products meet established safety standards. The agency continues to monitor licensed producers and manufacturers to verify compliance with potency, packaging, and testing requirements.

Patients with questions about the recalled product are encouraged to contact their dispensary directly. Anyone experiencing concerning symptoms related to cannabis consumption can contact the New Mexico Poison and Drug Information Center at 1-800-222-1222.

As New Mexico’s cannabis industry continues to mature, this recall serves as a reminder that regulatory oversight remains a central component of the state’s medical program.